Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glutaup is a nutritional supplement developed and marketed by Alniche Life Sciences, officially launched in 2022. It is designed for nutritional support and is distinguished by its use of 'Phytocell Technology,' which typically refers to the incorporation of plant-derived stem cell extracts intended to support cellular health and regeneration. While specific mechanistic details and full ingredient lists are not extensively detailed in clinical databases, the product is positioned within Alniche's broader portfolio of specialized nutrition and critical care therapies. It is administered orally and is used to provide supplemental nutrition in various clinical or wellness contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Glutaup.